References
- Fatima M , AbourehabMA, AggarwalGet al. Advancement of cell-penetrating peptides in combating triple-negative breast cancer. Drug Discov. Today121, 03353 (2022).
- De Martini LB , SulmonaC, BrambillaLet al. Cell-Penetrating Peptides as Valuable Tools for Nose-to-Brain Delivery of Biological Drugs. Cells12(12), 1643 (2023).
- Lundberg P , LangelÜ. A brief introduction to cell‐penetrating peptides. J. Mol. Recognit.16(5), 227–233 (2003).
- Koren E , TorchilinVP. Cell-penetrating peptides: breaking through to the other side. Trends Mol. Med.18(7), 385–393 (2012).
- Kurrikoff K , GestinM, LangelÜ. Recent in vivo advances in cell-penetrating peptide-assisted drug delivery. Expert. Opin. Drug. Dev.13(3), 373–387 (2016).
- Mäe M , MyrbergH, El-AndaloussiSet al. Design of a tumor homing cell-penetrating peptide for drug delivery. Int. J. Pept. Res. Ther.15, 11–15 (2009).
- Park SE , SajidMI, ParangKet al. Cyclic cell-penetrating peptides as efficient intracellular drug delivery tools. Mol Pharm.16(9), 3727–3743 (2019).
- Kardani K , MilaniA, HShabani S, BolhassaniA. Cell penetrating peptides: the potent multi-cargo intracellular carriers. Expert. Opin. Drug. Dev.16(11), 1227–1258 (2019).
- Szabó I , YousefMA, SoltészDet al. Redesigning of cell-penetrating peptides to improve their efficacy as a drug delivery system. Pharmaceutics14(5), 907–919 (2022).
- Wang X , ZhaoY, DongSet al. Cell-penetrating peptide and transferrin co-modified liposomes for targeted therapy of glioma. Molecules24(19), 3540 (2019).
- Xu J , KhanAR, FuMet al. Cell-penetrating peptide: a means of breaking through the physiological barriers of different tissues and organs. J. Control. Rel.309, 106–124 (2019).
- Xie J , BiY, ZhangH, DongSet al. Cell-penetrating peptides in diagnosis and treatment of human diseases: from preclinical research to clinical application. Front. Pharmacol.11, 697–716 (2020).
- Schneider AF , KithilM, CardosoMCet al. Cellular uptake of large biomolecules enabled by cell-surface-reactive cell-penetrating peptide additives. Nat. Chem.13(6), 530–539 (2021).
- Desale K , KucheK, JainS. Cell-penetrating peptides (CPPs): an overview of applications for improving the potential of nanotherapeutics. Biomater. Sci.9(4), 1153–1188 (2021).
- Teo SL , RennickJJ, YuenD, Al-WassitiHet al. Unravelling cytosolic delivery of cell penetrating peptides with a quantitative endosomal escape assay. Nat. Commun.12(1), 3721 (2021).
- Kurrikoff K , VunkB, LangelÜ. Status update in the use of cell-penetrating peptides for the delivery of macromolecular therapeutics. Expert Opin. Biol. Ther.21(3), 361–370 (2021).
- Morris MC , DepollierJ, MeryJet al. A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat. Biotechnol.19(2), 117–122 (2001).
- Futaki S , SuzukiT, OhashiWet al. Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J. Biol. Chem.276(19), 5836–5840 (2001).